Cancer Biomarkers
A cancer biomarker refers to a substance or technique this is indicative of the presence of cancer inside the frame. A biomarker may be a molecule secreted via a tumour or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycolic, and imaging biomarkers can be used for cancer prognosis, diagnosis, and epidemiology. Whilst a few most cancers biomarkers can be used to be expecting how aggressively your cancer will develop, and are consequently beneficial for assessing your analysis, the maximum promising use of biomarkers these days is to pick out which cures a patient’s cancer may additionally or might not respond to.
- Diagnostic Biomarkers
- Predictive & Prognostic Biomarkers
- Tumour Suppressors Biomarkers
- Molecular Cancer Biomarkers
Related Conference of Cancer Biomarkers
Cancer Biomarkers Conference Speakers
Recommended Sessions
- Cancer and Stem Cell Therapy
- Cancer Awareness and Survival
- Cancer Biomarkers
- Cancer Biopsy
- Cancer Cell Biology and Genetics
- Cancer Chemotherapy
- Cancer Metabolomics
- Cancer Metastasis
- Cancer Nanotechnology
- Cancer Pharmacology
- Cancer Prevention and Research
- Cancer Vaccines
- Cancer: Lifestyle Connection and Nutrition
- Cancer: Psychological and Social Aspects
- Complementary and Alternative Methods and Cancer
- Neonatal and Pediatric Oncology
- Oncology Nursing and Care
- Oncology: Sub-Specialties
- Organ-Defined Cancers
- Tumor Virology, Immunology and Cellular Pathology
Related Journals
Are you interested in
- Abdominal Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Advanced MRI Techniques in Oncology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Advancements in Early Detection and Precision Screening - Euro Breast Cancer 2026 (France)
- Advances in Brachytherapy Techniques - Euro Cancer 2026 (France)
- Advances in Immuno-Oncology and CAR-T Cell Therapies - CANCER2026 (France)
- Advances in Radiation Oncology - Euro Breast Cancer 2026 (France)
- Advances in Stereotactic Body Radiation Therapy (SBRT) - Euro Cancer 2026 (France)
- AI & Machine Learning in Oncology - Cancer Summit 2026 (France)
- AI and Machine Learning in Radiation Oncology - Euro Cancer 2026 (France)
- Artificial Intelligence and Digital Health in Breast Cancer - Breast Cancer Summit 2027 (France)
- Artificial Intelligence and Digital Innovations in Oncology - CANCER2026 (France)
- Artificial Intelligence in Cancer Radiology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Artificial Intelligence, Digital Health, and Big Data in Breast Cancer Care - Euro Breast Cancer 2026 (France)
- Biological Basis of Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Biomarker Discovery and Molecular Diagnostics in Cancer - CANCER2026 (France)
- Biomarkers for Radiation Response Prediction - Euro Cancer 2026 (France)
- Breast Cancer Awareness, Advocacy and Public Health - Breast Cancer Summit 2027 (France)
- Breast Cancer Biology and Tumor Microenvironment - Breast Cancer Summit 2027 (France)
- Breast Cancer During Pregnancy - Breast Cancer Summit 2027 (France)
- Breast Cancer in Young Women and Hereditary Syndromes - Euro Breast Cancer 2026 (France)
- Breast Cancer Prevention and Early Detection - Womens Health 2027 (France)
- Breast Cancer Prevention and Risk Assessment - Euro Breast Cancer 2026 (France)
- Breast Cancer Surgery and Reconstructive Oncology - Breast Cancer Summit 2027 (France)
- Breast Cancer, Cancer Therapies And Breast Cancer Treatment - Women Oncology-2026 (USA)
- Breast, Lung, Colorectal & Prostate Cancer Studies - Cancer Summit 2026 (France)
- Cancer & Biopsies - Cancer diagnostics 2026 (USA)
- Cancer Awareness and Survival - World Cancer-2026 (UAE)
- Cancer Biology - Women Oncology-2026 (USA)
- Cancer Biology & Tumor Microenvironment - Cancer Summit 2026 (France)
- Cancer Biomarker - Cancer diagnostics 2026 (USA)
- Cancer Biomarkers - Women Oncology-2026 (USA)
- Cancer Cell Biology & Genetics - World Cancer-2026 (UAE)
- Cancer Clinical Trails - Cancer diagnostics 2026 (USA)
- Cancer Development - Women Oncology-2026 (USA)
- Cancer Diagnostics Market - Cancer diagnostics 2026 (USA)
- Cancer Diagnostics Tools, Technologies and Procedures - Cancer diagnostics 2026 (USA)
- Cancer Drugs - Women Oncology-2026 (USA)
- Cancer Epidemiology - World Cancer-2026 (UAE)
- Cancer Epidemiology, Screening, Diagnosis & Prognosis - Women Oncology-2026 (USA)
- Cancer Genomics and Epigenetics - Cancer diagnostics 2026 (USA)
- Cancer Genomics, Epigenetics & Biomarkers - Cancer Summit 2026 (France)
- Cancer Health Disparities - Women Oncology-2026 (USA)
- Cancer Immunology & Immunotherapy - World Cancer-2026 (UAE)
- Cancer Immunotherapy and Types - Cancer diagnostics 2026 (USA)
- Cancer Nanotechnology - Cancer diagnostics 2026 (USA)
- Cancer Nanotechnology - World Cancer-2026 (UAE)
- Cancer Pharmacology - World Cancer-2026 (UAE)
- Cancer Prevention, Genetics and Risk Assessment - Breast Cancer Summit 2027 (France)
- Cancer Prevention, Lifestyle & Public Health - Cancer Summit 2026 (France)
- Cancer Prevention, Screening, and Public Health Strategies - CANCER2026 (France)
- Cancer Preventive Vaccines: Oncolytic Therapy & Others - Women Oncology-2026 (USA)
- Cancer Radiology - Cancer diagnostics 2026 (USA)
- Cancer Risk Factors - Women Oncology-2026 (USA)
- Cancer Science - Women Oncology-2026 (USA)
- Cancer Screening and Diagnostic Innovation - Womens Health 2027 (France)
- Cancer Stem Cells - Women Oncology-2026 (USA)
- Cancer Survivorship and Rehabilitation - Womens Health 2027 (France)
- Cancer Treatment - Women Oncology-2026 (USA)
- Cancer Treatment and Therapeutic Developments - Womens Health 2027 (France)
- Cancer Treatment and Therapies - Cancer diagnostics 2026 (USA)
- Cancer vaccines - Women Oncology-2026 (USA)
- Cancer Vaccines and Therapeutics - Cancer diagnostics 2026 (USA)
- Cancer: Psychological & Social factors - World Cancer-2026 (UAE)
- Cancers & Stem Cell therapy - World Cancer-2026 (UAE)
- Cancers Biomarkers - World Cancer-2026 (UAE)
- Cancers Biopsy - World Cancer-2026 (UAE)
- Cancers Chemotherapy - World Cancer-2026 (UAE)
- Cancers Metabolomics - World Cancer-2026 (UAE)
- Cancers Metastasis - World Cancer-2026 (UAE)
- Cancers Prevention & Research - World Cancer-2026 (UAE)
- Cancers Therapy & Treatments - World Cancer-2026 (UAE)
- Cancers Vaccines - World Cancer-2026 (UAE)
- Cancers: lifestyle Connection and Nutrition - World Cancer-2026 (UAE)
- Cardio Oncology - Women Oncology-2026 (USA)
- Cell Cycle Regulation in Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Cellular Plasticity in Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Cellular Polarity and Asymmetric Division - Cancer Stem Cells 2027 (Italy)
- Cellular Stress Response in Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Cervical Cancer Prevention and HPV - Womens Health 2027 (France)
- Chromatin Organization and Cellular Identity - Cancer Stem Cells 2027 (Italy)
- Circulating Tumor Cell (CTC) - Women Oncology-2026 (USA)
- Climate, Environment and Women's Health - Womens Health 2027 (France)
- Clinical Cancer research - Cancer diagnostics 2026 (USA)
- Clinical Trials & Translational Cancer Research - Cancer Summit 2026 (France)
- Clinical Trials and Cancer Research - Womens Health 2027 (France)
- Clinical Trials and Translational Research - Breast Cancer Summit 2027 (France)
- Clinical Trials in Advanced Radiation Therapy - Euro Cancer 2026 (France)
- Clinical Trials, Drug Discovery, and Translational Research - Euro Breast Cancer 2026 (France)
- Combination Therapies in Metastatic Cancer Management - Euro Cancer 2026 (France)
- Complementary & Alternate Methods and Cancer - World Cancer-2026 (UAE)
- CyberKnife and Robotic Radiosurgery Developments - Euro Cancer 2026 (France)
- Digital Health and Artificial Intelligence - Womens Health 2027 (France)
- Digital Health, Telemedicine & Oncology Data Science - Cancer Summit 2026 (France)
- Digital Oncology, Big Data, and Treatment Optimization - Euro Cancer 2026 (France)
- DNA Damage Response Mechanisms - Cancer Stem Cells 2027 (Italy)
- Early Cancer Detection and Liquid Biopsy Technologies - CANCER2026 (France)
- Early Detection, Screening & Diagnostic Technologies - Cancer Summit 2026 (France)
- Early Detection, Screening and Diagnosis - Breast Cancer Summit 2027 (France)
- Early-Onset Cancers in Women Under 50 - Womens Health 2027 (France)
- Emerging Therapies and Future Directions in Oncology - CANCER2026 (France)
- Endometriosis, PCOS and Benign Gynaecological Conditions - Womens Health 2027 (France)
- Epigenetic Regulation in Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Epigenetics and Gene Editing in Cancer Therapy - CANCER2026 (France)
- Evolutionary Dynamics of Cancer Stem Cell Populations - Cancer Stem Cells 2027 (Italy)
- Future Directions in Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Future Innovations in Breast Cancer Research and Precision Medicine - Breast Cancer Summit 2027 (France)
- Future Trends in Oncology Technology and Global Impact - Euro Cancer 2026 (France)
- Gene Editing & CRISPR in Cancer - World Cancer-2026 (UAE)
- Genetic Instability and Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Genetic Mutations Of Cancer - Women Oncology-2026 (USA)
- Genetic Risk and Hereditary Cancers - Womens Health 2027 (France)
- Global Access to Radiation Therapy and Health Equity - Euro Cancer 2026 (France)
- Global Collaboration and Equitable Breast Cancer Care - Euro Breast Cancer 2026 (France)
- Global Oncology Trends and Future Perspectives - CANCER2026 (France)
- Gynecologic Oncology - Women Oncology-2026 (USA)
- Gynecologic Oncology and Cancer Care - Womens Health 2027 (France)
- Health Economics, Access, and Policy in Oncology - CANCER2026 (France)
- Hematologic Malignancies & Blood Cancers - Cancer Summit 2026 (France)
- HER2-Positive and HER2-Low Breast Cancer - Euro Breast Cancer 2026 (France)
- Hormone Receptor-Positive Breast Cancer: Evolving Treatment Strategies - Euro Breast Cancer 2026 (France)
- Hybrid Imaging Technologies - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Hypofractionation and Ultra-Short Radiation Protocols - Euro Cancer 2026 (France)
- Hypoxia and Cancer Stem Cell Biology - Cancer Stem Cells 2027 (Italy)
- Image-Guided and MRI-Guided Radiotherapy - Euro Cancer 2026 (France)
- Image-Guided Interventional Oncology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Imaging-Guided Radiation Oncology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Immunotherapy & Targeted Therapy Advances - Cancer Summit 2026 (France)
- Immunotherapy and Emerging Cancer Therapies - Womens Health 2027 (France)
- Immunotherapy and Emerging Therapeutic Innovations - Breast Cancer Summit 2027 (France)
- Immunotherapy and Next-Generation Cancer Vaccines - CANCER2026 (France)
- Immunotherapy and Next-Generation Targeted Therapies - Euro Breast Cancer 2026 (France)
- Immunotherapy and Radiation Synergy Strategies - Euro Cancer 2026 (France)
- Industry Innovations in Radiation Delivery Systems - Euro Cancer 2026 (France)
- Inflammation Driven Regulation of Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Innovations in Breast Cancer Surgery - Euro Breast Cancer 2026 (France)
- Intercellular Communication Within Tumors - Cancer Stem Cells 2027 (Italy)
- Lung Cancer in Women — The Overlooked Epidemic - Womens Health 2027 (France)
- Male Breast Cancer - Breast Cancer Summit 2027 (France)
- Maternal Health and Pregnancy Care - Womens Health 2027 (France)
- Menopause and Midlife Women's Health - Womens Health 2027 (France)
- Mental Health and Psycho-Oncology - Womens Health 2027 (France)
- Metabolic Characteristics of Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Metastatic Breast Cancer - Breast Cancer Summit 2027 (France)
- Metastatic Breast Cancer: Improving Survival and Quality of Life - Euro Breast Cancer 2026 (France)
- Migration and Invasive Properties of Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Molecular Imaging and Functional Oncology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Multidisciplinary Approaches and Integrated Cancer Care - CANCER2026 (France)
- Musculoskeletal Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Nanotechnology and Drug Delivery Innovations in Cancer Therapy - CANCER2026 (France)
- Nanotechnology In Cancer Treatment - Women Oncology-2026 (USA)
- Neonatal & Pediatric Oncology - World Cancer-2026 (UAE)
- Neonatal And Pediatric Oncology - Women Oncology-2026 (USA)
- Neuro-Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Oncology Artificial Intelligence for Drug Discovery and Clinical Decision Support - CANCER2026 (France)
- Oncology Clinical Trials and Translational Research - CANCER2026 (France)
- Oncology Nursing - Women Oncology-2026 (USA)
- Oncology Nursing & Palliative Care - Cancer Summit 2026 (France)
- Oncology Nursing and Care - World Cancer-2026 (UAE)
- Oncology Nursing and Multidisciplinary Breast Cancer Care - Breast Cancer Summit 2027 (France)
- Oncology Research - Women Oncology-2026 (USA)
- Organ Specific Cancer - Women Oncology-2026 (USA)
- Organ-defined Cancers - World Cancer-2026 (UAE)
- Palliative, Supportive, and End-of-Life Care - Womens Health 2027 (France)
- Pediatric Oncology & Rare Cancers - Cancer Summit 2026 (France)
- Pediatric Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Pediatric Radiation Oncology: Precision and Safety - Euro Cancer 2026 (France)
- PET Imaging and Metabolic Oncology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Pharma Innovations & Drug Discovery in Oncology - Cancer Summit 2026 (France)
- Phases And Types Of Clinical Trails - Women Oncology-2026 (USA)
- Precision Cancers Medicinal Drug & Oncology - World Cancer-2026 (UAE)
- Precision Imaging for Early Cancer Identification - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Precision Medicine & Personalized Cancer Treatment - Cancer Summit 2026 (France)
- Precision Medicine And Immuno-Oncology - Women Oncology-2026 (USA)
- Precision Oncology and Genomic Medicine - Euro Breast Cancer 2026 (France)
- Precision Oncology and Personalized Cancer Therapy - CANCER2026 (France)
- Precision Oncology for Women - Womens Health 2027 (France)
- Precision Oncology in Breast Cancer - Breast Cancer Summit 2027 (France)
- Precision Radiotherapy and Adaptive Treatment Planning - Euro Cancer 2026 (France)
- Predictive Cancer Biomarkers - Cancer diagnostics 2026 (USA)
- Proton Therapy and Particle Beam Innovations - Euro Cancer 2026 (France)
- Public Awareness and Cancer Education - Womens Health 2027 (France)
- Pulmonary Oncology - Women Oncology-2026 (USA)
- Quiescence and Dormancy in Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Radiation Oncology - Women Oncology-2026 (USA)
- Radiation Oncology & Advanced Radiotherapy Techniques - Cancer Summit 2026 (France)
- Radiation Oncology and Precision Radiotherapy - Breast Cancer Summit 2027 (France)
- Radiation Oncology in Low- and Middle-Income Countries - Euro Cancer 2026 (France)
- Radiation-Induced Toxicity and Mitigation Strategies - Euro Cancer 2026 (France)
- Radiogenomics and Personalized Cancer Treatment - Euro Cancer 2026 (France)
- Radiologic Mapping of Tumor Microenvironments - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Radiology in Breast Oncology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Radiology in Cancer Survivorship - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Radiology in Immuno-Oncology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Radiology in Surgical Oncology Planning - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Radiomics and Quantitative Image Analysis - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Radiopharmaceuticals and Molecular Targeted Radiation - Euro Cancer 2026 (France)
- Radiotherapy Innovations and Precision Surgical Oncology - CANCER2026 (France)
- Re-Irradiation Strategies and Complex Case Management - Euro Cancer 2026 (France)
- Recent Diagnostics Technologies - Cancer diagnostics 2026 (USA)
- Reproductive Health and Fertility Preservation - Womens Health 2027 (France)
- Role of the Tumor Microenvironment in Cancer Stem Cell Maintenance - Cancer Stem Cells 2027 (Italy)
- Self Renewal and Differentiation Mechanisms - Cancer Stem Cells 2027 (Italy)
- Stemness Gene Networks in Cancer - Cancer Stem Cells 2027 (Italy)
- Supportive Care, Palliative Oncology, and Patient-Centric Approaches - CANCER2026 (France)
- Surgical Oncology & Minimally Invasive Procedures - Cancer Summit 2026 (France)
- Survivorship, Rehabilitation, and Long-Term Care in Oncology - CANCER2026 (France)
- Survivorship, Rehabilitation, and Supportive Care - Euro Breast Cancer 2026 (France)
- Survivorship, Supportive Care and Quality of Life - Breast Cancer Summit 2027 (France)
- Targeted Therapies and Personalized Treatment Strategies - Breast Cancer Summit 2027 (France)
- Targeted Therapies Combined with Radiation - Euro Cancer 2026 (France)
- Targeted Therapy and Molecular Oncology Advances - CANCER2026 (France)
- Tele-Oncology and Digital Health in Cancer Care - CANCER2026 (France)
- Thoracic Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Translational Research in Radiation Oncology - Euro Cancer 2026 (France)
- Triple-Negative Breast Cancer: New Frontiers in Treatment - Euro Breast Cancer 2026 (France)
- Triple-Negative, HER2-Positive and Hormone Receptor-Positive Breast Cancer - Breast Cancer Summit 2027 (France)
- Tumor Cellular Heterogeneity and Stem Cell Hierarchy - Cancer Stem Cells 2027 (Italy)
- Tumor Microenvironment and Radiosensitivity - Euro Cancer 2026 (France)
- Tumor Virology, Immunology & Mobile Pathology - World Cancer-2026 (UAE)
- Types Of Cancers - Women Oncology-2026 (USA)
- Veterinary Oncology - Women Oncology-2026 (USA)
- Women's Cardiovascular and Metabolic Health - Womens Health 2027 (France)
- Women's Health Across the Life Course - Womens Health 2027 (France)
- Women's Health in Underserved Communities - Womens Health 2027 (France)
- Women's Microbiome, Gut Health and Hormonal Balance - Womens Health 2027 (France)